For three upregulated genes of the late phase, Sema6a, Ntng2, and TGF-β1, the potential to overcome spinal cord extract mediated growth-inhibition was shown in an in vitro neurite outgrowth assay, suggesting their role as growth-promoters in the spinal GM after stroke. Here, TGFB1 is linked to stroke disorder.